Zhitong Finance App News, Luxin Biotechnology (01084.HK) issued an announcement. After preliminary review of available information (including but not limited to the Group's unaudited comprehensive management accounts for the six months ended June 30, 2026 (reporting period)), the board of directors hereby informs the Company's shareholders (shareholders) and interested investors that during the reporting period, the Company expects to obtain a net loss attributable to the owners of the Company ranged from approximately RMB 1 million to RMB 4 million, and the net loss attributable to the Company's owners for the six months ended June 30, 2025 was RMB 1.07 million yuan.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.